Elanco Animal Health Incorporated

32.41-0.5100-1.55%Vol 3.57M1Y Perf 20.79%
Sep 15th, 2021 16:00 DELAYED
BID31.56 ASK33.34
Open32.85 Previous Close32.92
Pre-Market- After-Market-
 - -%  - -
Target Price
36.67 
Analyst Rating
Moderate Buy 1.80
Potential %
13.14 
Finscreener Ranking
★★★+     50.84
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★     45.70
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★     45.66
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
56.69 
Earnings Rating
Sell
Market Cap15.33B 
Earnings Date
5th Nov 2021
Alpha-0.01 Standard Deviation0.10
Beta0.91 

Today's Price Range

32.1132.90

52W Range

25.7637.49

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-3.37%
1 Month
2.79%
3 Months
-9.92%
6 Months
-3.46%
1 Year
20.79%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
ELAN32.41-0.5100-1.55
AAPL149.030.91000.61
GOOG2 904.1236.00001.26
MSFT304.825.03001.68
XOM56.421.84003.37
WFC46.640.59001.28
JNJ165.420.62000.38
FB373.92-2.6100-0.69
GE102.161.78001.77
JPM158.161.09000.69
Financial StrengthValueIndustryS&P 500US Markets
0.90
1.70
0.41
0.76
-2.70
Leverage Ratio 2.10
ProfitabilityValueIndustryS&P 500US Markets
52.60
-13.50
2.50
-4.60
-15.98
RevenueValueIndustryS&P 500US Markets
4.55B
9.62
8.62
7.90
Earnings HistoryEstimateReportedSurprise %
Q02 20210.260.287.69
Q01 20210.230.3760.87
Q04 20200.090.1233.33
Q03 20200.120.138.33
Q02 20200.020.09350.00
Q01 20200.240.13-45.83
Q04 20190.230.230.00
Q03 20190.260.3015.38
Earnings Per EndEstimateRevision %Trend
9/2021 QR0.17-10.53Negative
12/2021 QR0.19-17.39Negative
12/2021 FY1.01-1.94Negative
12/2022 FY1.29-2.27Negative
Next Report Date5th Nov 2021
Estimated EPS Next Report0.17
Estimates Count5
EPS Growth Next 5 Years %49.80
Volume Overview
Volume3.57M
Shares Outstanding473.02M
Shares Float444.12M
Trades Count22.77K
Dollar Volume171.83M
Avg. Volume3.79M
Avg. Weekly Volume2.38M
Avg. Monthly Volume3.06M
Avg. Quarterly Volume3.72M

Elanco Animal Health Incorporated (NYSE: ELAN) stock closed at 32.41 per share at the end of the most recent trading day (a -1.55% change compared to the prior day closing price) with a volume of 3.57M shares and market capitalization of 15.33B. Is a component of Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 6080 people. Elanco Animal Health Incorporated CEO is Jeffrey N. Simmons.

The one-year performance of Elanco Animal Health Incorporated stock is 20.79%, while year-to-date (YTD) performance is 5.67%. ELAN stock has a five-year performance of %. Its 52-week range is between 25.76 and 37.49, which gives ELAN stock a 52-week price range ratio of 56.69%

Elanco Animal Health Incorporated currently has a PE ratio of -21.50, a price-to-book (PB) ratio of 1.98, a price-to-sale (PS) ratio of 3.46, a price to cashflow ratio of 83.40, a PEG ratio of 2.32, a ROA of -5.35%, a ROC of -4.66% and a ROE of -9.72%. The company’s profit margin is -15.98%, its EBITDA margin is 2.50%, and its revenue ttm is $4.55 Billion , which makes it $9.62 revenue per share.

Of the last four earnings reports from Elanco Animal Health Incorporated, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.17 for the next earnings report. Elanco Animal Health Incorporated’s next earnings report date is 05th Nov 2021.

The consensus rating of Wall Street analysts for Elanco Animal Health Incorporated is Moderate Buy (1.8), with a target price of $36.67, which is +13.14% compared to the current price. The earnings rating for Elanco Animal Health Incorporated stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Elanco Animal Health Incorporated has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Elanco Animal Health Incorporated has a Sell technical analysis rating based on Technical Indicators (ADX : 12.40, ATR14 : 0.78, CCI20 : -42.70, Chaikin Money Flow : 0.13, MACD : -0.05, Money Flow Index : 62.71, ROC : -2.70, RSI : 40.76, STOCH (14,3) : 14.22, STOCH RSI : 0.00, UO : 46.93, Williams %R : -85.78), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Elanco Animal Health Incorporated in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
6 (60.00 %)
5 (50.00 %)
5 (50.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
1 (10.00 %)
Hold
4 (40.00 %)
5 (50.00 %)
4 (40.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
1.80
Moderate Buy
2.00
Moderate Buy
1.85

Elanco Animal Health Incorporated

Elanco Animal Health Inc is an animal health company that is engaged in innovating, developing, manufacturing, and marketing products for companion and food animals. Geographically, the company derives revenue from North America, Europe, the Middle East and Africa, Latin America, and the Asia Pacific with the highest revenue from the North America segment. It offers a range of food animal products used in cattle, sheep, goats, and swine production.

CEO: Jeffrey N. Simmons

Telephone: +1 877 352-6261

Address: 2500 Innovation Way, Greenfield 46140, IN, US

Number of employees: 6 080

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

54%46%

Bearish Bullish

50%50%

Bearish Bullish

52%48%

TipRanks News for ELAN

Fri, 13 Aug 2021 07:19 GMT What Do Elancos Earnings and Risk Factors Tell Investors

- TipRanks. All rights reserved.

News

Stocktwits